19.12.2013 • Topics

Regions & Locations Guide 2013

Regions & Locations Guide 2013

Print edition as epaper.

WORLD

Global Competitiveness Index
Institutions and Innovation Increasingly Important for Competitiveness of Locations
Jennifer Blanke, World Economic Forum

Global Investment Opportunities in Pharmaceuticals

EUROPE

European Chemical Industry Parks 2.0
How to Sustainably Increase the Competitiveness of European Sites
Christoph Behrendt, Scopein Management Consultants

The Lacq Gas Basin, a Model Industrial Reconversion

Chemicals and Plastics in North-Rine-Westphalia
NRW.Invest

EMERGING MARKETS

Risky Business
Nuances of Insurance in Emerging Markets
Nigel Todd, FM Global

MIDDLE EAST

Chemicals in the Middle East
The Drive Toward Downstream Expansion
Vir Lakshman and Rita Duran, KPMG

Bringing Innovation and Industrialization to Life
Bahrain is an Attractive Base for Accessing the GCC Market
Dr. Michael Reubold, CHEManager

ASIA

Spoiled for Choice
Chemical Parks and Site Selection in China
Dr. Kai Pflug, Management Consulting – Chemicals

Doing Business the Indian Way
Multinationals Must Adapt to Local Practices
Vimal Choudhary, Alok Kshirsagnar, Ananth Narayanan, McKinsey

NORTH AMERICA

A Game Changer
New Digital Pathology System for Cancer Diagnoses Set up in Ontario
Dr. Terrie Romano, Ontario International Marketing Centre

Turning Sarnia Green
Hybrid Chemistry Center Sprouts from Petroleum-Based Cluster
Murray McLaughlin, Biodindustrial Innovation Centre Sarnia

Wave of New Investments in US Manufacturing

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read